Association between a promoter polymorphism (rs2192752, -1028A/C) of interleukin 1 receptor, type I (IL1R1) and location of papillary thyroid carcinoma in a Korean population

International Journal of Immunogenetics

Volumn 39, Issue 6, 2012, Pages 501-507

  Park, S W ^a   Kim, M K ^a   Kwon, K H ^a   Kim, J ^b  

^a Kyung Hee University Hospital   (South Korea)

^b Kyung Hee University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALLELE; ARTICLE; CANCER INVASION; DNA POLYMORPHISM; FEMALE; GENE; GENE FREQUENCY; GENOTYPE; HUMAN; INTERLEUKIN 1 RECEPTOR, TYPE 1 GENE; KOREA; MAJOR CLINICAL STUDY; MALE; METASTASIS; POPULATION RESEARCH; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; THYROID CARCINOMA; TUMOR VOLUME;

ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA; CASE-CONTROL STUDIES; DEMOGRAPHY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RECEPTORS, INTERLEUKIN-1 TYPE I; REPUBLIC OF KOREA; THYROID GLAND; THYROID NEOPLASMS;

EID: 84868640443     PISSN: 17443121     EISSN: 1744313X     Source Type: Journal    
DOI: 10.1111/j.1744-313X.2012.01125.x     Document Type: Article

References (30)

1. Borrello, M.G., Alberti, L., Fischer, A., Degl'innocenti, D., Ferrario, C., Gariboldi, M. et al. (2005) Induction of a proinflammatory program in normal human thyrocytes by the RET/PTC1 oncogene. Proceedings of the National Academy of Sciences of the United States of America, 102, 14825.
2. Canzian, F., Amati, P., Harach, H.R., Kraimps, J.L., Lesueur, F., Barbier, J., Levillain, P., Romeo, G. & Bonneau, D. (1998) A gene predisposing to familial thyroid tumors with cell oxyphilia maps to chromosome 19p13.2. American journal of human genetics, 63, 1743.
3. Chen, A.Y., Jemal, A. & Ward, E.M. (2009) Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005. Cancer, 115, 3801.
4. Chien, M.H., Yeh, C.B., Li, Y.C., Wei, L.H., Chang, J.H., Peng, Y.T., Yang, S.F. & Kuo, W.H. (2011) Relationship of interleukin-8 gene polymorphisms with hepatocellular carcinoma susceptibility and pathological development. Journal of surgical oncology, 104, 798.
5. Delys, L., Detours, V., Franc, B., Thomas, G., Bogdanova, T., Tronko, M., Libert, F., Dumont, J.E. & Maenhaut, C. (2007) Gene expression and the biological phenotype of papillary thyroid carcinomas. Oncogene, 26, 7894.
6. Dinarello, C.A. (1998) Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist. International reviews of immunology, 16, 457.
7. El-Omar, E.M., Rabkin, C.S., Gammon, M.D., Vaughan, T.L., Risch, H.A., Schoenberg, J.B. et al. (2003) Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology, 124, 1193.
8. Eun, Y.G., Hong, I.K., Kim, S.K., Park, H.K., Kwon, S., Chung, D.H. & Kwon, K.H. (2011) A Polymorphism (rs1801018, Thr7Thr) of BCL2 is Associated with Papillary Thyroid Cancer in Korean Population. Clinical and experimental otorhinolaryngology, 4, 149.
9. Giancotti, V., Berlingieri, M.T., DiFiore, P.P., Fusco, A., Vecchio, G. & Crane-Robinson, C. (1985) Changes in nuclear proteins on transformation of rat epithelial thyroid cells by a murine sarcoma retrovirus. Cancer research, 45, 6051.
10. Han, W., Kang, S.Y., Kang, D., Park, S.K., Lee, J.Y., Kim, H., Park, A.K. & Noh, D.Y. (2010) Multiplex genotyping of 1107 SNPs from 232 candidate genes identified an association between IL1A polymorphism and breast cancer risk. Oncology reports, 23, 763.
11. Hefler, L.A., Grimm, C., Lantzsch, T., Lampe, D., Leodolter, S., Koelbl, H. et al. (2005) Interleukin-1 and interleukin-6 gene polymorphisms and the risk of breast cancer in caucasian women. Clinical cancer research, 11, 5718.
12. Huang, Y., Prasad, M., Lemon, W.J., Hampel, H., Wright, F.A., Kornacker, K. et al. (2001) Gene expression in papillary thyroid carcinoma reveals highly consistent profiles. Proceedings of the National Academy of Sciences of the United States of America, 98, 15044.
13. Jarzab, B., Wiench, M., Fujarewicz, K., Simek, K., Jarzab, M., Oczko-Wojciechowska, M. et al. (2005) Gene expression profile of papillary thyroid cancer: sources of variability and diagnostic implications. Cancer research, 65, 1587.
14. Knostman, K.A., Jhiang, S.M. & Capen, C.C. (2007) Genetic alterations in thyroid cancer: the role of mouse models. Veterinary pathology, 44, 1.
15. Koch, I., Depenbrock, H., Danhauser-Riedl, S., Rastetter, J.W. & Hanauske, A.R. (1995) Interleukin 1 modulates growth of human renal carcinoma cells in vitro. British journal of cancer, 71, 794.
16. Lind, H., Zienolddiny, S., Ryberg, D., Skaug, V., Phillips, D.H. & Haugen, A. (2005) Interleukin 1 receptor antagonist gene polymorphism and risk of lung cancer: a possible interaction with polymorphisms in the interleukin 1 beta gene. Lung Cancer, 50, 285.
17. LiVolsi, V.A. & Baloch, Z.W. (2004) Follicular neoplasms of the thyroid: view, biases, and experiences. Advances in anatomic pathology, 11, 279.
18. McMahan, C.J., Slack, J.L., Mosley, B., Cosman, D., Lupton, S.D., Brunton, L.L. et al. (1991) A novel IL-1 receptor, cloned from B cells by mammalian expression, is expressed in many cell types. The EMBO journal, 10, 2821.
19. Mirallie, E., Visset, J., Sagan, C., Hamy, A., Le Bodic, M.F. & Paineau, J. (1999) Localization of cervical node metastasis of papillary thyroid carcinoma. World journal of surgery, 23, 970, discussion 973.
20. Nakki, A., Kouhia, S.T., Saarela, J., Harilainen, A., Tallroth, K., Videman, T., Battie, M.C., Kaprio, J., Peltonen, L. & Kujala, U.M. (2010) Allelic variants of IL1R1 gene associate with severe hand osteoarthritis. BMC medical genetics, 11, 50.
21. Persson, C., Engstrand, L., Nyren, O., Hansson, L.E., Enroth, H., Ekstrom, A.M. & Ye, W. (2009) Interleukin 1-beta gene polymorphisms and risk of gastric cancer in Sweden. Scandinavian journal of gastroenterology, 44, 339.
22. Powell Jr, D.J., Eisenlohr, L.C. & Rothstein, J.L. (2003) A thyroid tumor-specific antigen formed by the fusion of two self proteins. The Journal of immunology, 170, 861.
23. Ravindran, J.S., Owen, P., Lagan, A., Lewis, J., Korendowych, E., Welsh, K. & McHugh, N. (2004) Interleukin 1alpha, interleukin 1beta and interleukin 1 receptor gene polymorphisms in psoriatic arthritis. Rheumatology (Oxford), 43, 22.
24. Ryckman, K.K., Fielding, K., Hill, A.V., Mendy, M., Rayco-Solon, P., Sirugo, G. et al. (2010) Host genetic factors and vaccine-induced immunity to HBV infection: haplotype analysis. PLoS ONE, 5, e12273.
25. Sims, J.E., Gayle, M.A., Slack, J.L., Alderson, M.R., Bird, T.A., Giri, J.G. et al. (1993) Interleukin 1 signaling occurs exclusively via the type I receptor. Proceedings of the National Academy of Sciences of the United States of America, 90, 6155.
26. Smith, A.J., Keen, L.J., Billingham, M.J., Perry, M.J., Elson, C.J., Kirwan, J.R., Sims, J.E., Doherty, M., Spector, T.D. & Bidwell, J.L. (2004) Extended haplotypes and linkage disequilibrium in the IL1R1-IL1A-IL1B-IL1RN gene cluster: association with knee osteoarthritis. Genes and immunity, 5, 451.
27. Solovieva, S., Kamarainen, O.P., Hirvonen, A., Hamalainen, S., Laitala, M., Vehmas, T. et al. (2009) Association between interleukin 1 gene cluster polymorphisms and bilateral distal interphalangeal osteoarthritis. The Journal of rheumatology, 36, 1977.
28. Streicher, K.L., Willmarth, N.E., Garcia, J., Boerner, J.L., Dewey, T.G. & Ethier, S.P. (2007) Activation of a nuclear factor kappaB/interleukin-1 positive feedback loop by amphiregulin in human breast cancer cells. Molecular cancer research, 5, 847.
29. Tamandani, D.M., Sobti, R.C., Shekari, M., Kaur, S. & Huria, A. (2008) Impact of polymorphism in IL-1RA gene on the risk of cervical cancer. Archives of gynecology and obstetrics, 277, 527.
30. Ye, K., Vannier, E., Clark, B.D., Sims, J.E. & Dinarello, C.A. (1996) Three distinct promoters direct transcription of different 5′ untranslated regions of the human interleukin 1 type I receptor: a possible mechanism for control of translation. Cytokine, 8, 421.